Loading…

Residue depletion profiles and withdrawal interval estimations of meloxicam in eggs and ovarian follicles following intravenous (Meloxicam solution for injection) and oral (Meloxidyl®) administration in domestic chickens (Gallus domesticus)

Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) commonly prescribed in an extralabel manner for treating chickens in urbanized settings. The objectives of this study were to determine meloxicam depletion profiles in eggs and ovarian follicles and to estimate associated withdrawal interva...

Full description

Saved in:
Bibliographic Details
Published in:Regulatory toxicology and pharmacology 2022-07, Vol.132, p.105170-105170, Article 105170
Main Authors: Yuan, Long, Lin, Zhoumeng, Dutch, Rachel S., Richards, Emily D., Clapham, Maaike O., Burmas, Nathaniel, Wetzlich, Scott E., Tell, Lisa A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c334t-d07fa81c0b4561d5e72252559a1118f12035b3d8baebae6512870f902deb50383
cites cdi_FETCH-LOGICAL-c334t-d07fa81c0b4561d5e72252559a1118f12035b3d8baebae6512870f902deb50383
container_end_page 105170
container_issue
container_start_page 105170
container_title Regulatory toxicology and pharmacology
container_volume 132
creator Yuan, Long
Lin, Zhoumeng
Dutch, Rachel S.
Richards, Emily D.
Clapham, Maaike O.
Burmas, Nathaniel
Wetzlich, Scott E.
Tell, Lisa A.
description Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) commonly prescribed in an extralabel manner for treating chickens in urbanized settings. The objectives of this study were to determine meloxicam depletion profiles in eggs and ovarian follicles and to estimate associated withdrawal intervals (WDI) in laying hens following a single intravenous or repeated oral administration. The observed peak concentration of meloxicam in ovarian follicles were consistently higher than in egg yolk and egg white samples. Terminal half-lives were 31-h, 113-h and 12-h in ovarian follicles, egg yolk and egg white samples, respectively, for repeated oral administrations at 1 mg/kg for 20 doses at 12-h intervals. The terminal half-life following a single intravenous administration at 1 mg/kg was 50-h for ovarian follicles. Meloxicam WDI estimations using ovarian follicle and egg yolk concentration data following 20 doses at 12-h intervals were 36 and 12 days, respectively. Meloxicam WDI estimation using egg yolk concentration data following 8 doses at 24-h intervals was 12 days. These results improve our understanding on the residue depletion of meloxicam from chickens’ reproductive tracts and egg products and provide WDIs to help ensure food safety for humans consuming eggs from treated laying hens. •Meloxicam residue depletion kinetics in eggs and follicles of chickens was studied.•Maximum concentration in ovarian follicles was higher than in egg yolk and white.•Withdrawal interval (WDI) was 12 days in egg yolk after repeated oral exposures.•WDI was 36 days based on follicle data after repeated oral administrations.•The results help derive extralabel WDI to provide safe egg products.
doi_str_mv 10.1016/j.yrtph.2022.105170
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2654279748</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0273230022000575</els_id><sourcerecordid>2654279748</sourcerecordid><originalsourceid>FETCH-LOGICAL-c334t-d07fa81c0b4561d5e72252559a1118f12035b3d8baebae6512870f902deb50383</originalsourceid><addsrcrecordid>eNp9UU2O0zAUjhCIKQMnQEJedhYpz06cnwULNBpmkAYhIVhbjv3SujhxsZOWXopDcCNuME7TmSWSJdvP38_z-5LkLYUVBVq8366OfthtVgwYixVOS3iWLCjURQqs5s-TBbAyS1kGcJG8CmELAKyqypfJRcbzAiqgi-TfNwxGj0g07iwOxvVk511rLAYie00OZthoLw_SEtMP6PfxgGEwnZywgbiWdGjdb6NkFxEE1-uZ6PbSG9mT1llr1CQ3ndzB9OtJycs99m4MZPnliR6cHU8dtM5HzBbVdLua5Xw0PmP10f79E8u6M70JUepEiubadVNviqiNUT8xtre8ldZGl8eXMVy9Tl600gZ8c94vkx-fbr5f36X3X28_X3-8T1WW5UOqoWxlRRU0OS-o5lgyxhnntaSUVi1lkPEm01UjMa6CU1aV0NbANDYcsiq7TJazbpznrzG6i84EhdbKHuPHBSt4zsq6zCdoNkOVdyF4bMXOxwn7o6AgpqzFVpyyFlPWYs46st6dDcamQ_3EeQw3Aj7MAIzf3Bv0IiiDvUJtfJyt0M781-ABSbHDiw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2654279748</pqid></control><display><type>article</type><title>Residue depletion profiles and withdrawal interval estimations of meloxicam in eggs and ovarian follicles following intravenous (Meloxicam solution for injection) and oral (Meloxidyl®) administration in domestic chickens (Gallus domesticus)</title><source>ScienceDirect Freedom Collection</source><creator>Yuan, Long ; Lin, Zhoumeng ; Dutch, Rachel S. ; Richards, Emily D. ; Clapham, Maaike O. ; Burmas, Nathaniel ; Wetzlich, Scott E. ; Tell, Lisa A.</creator><creatorcontrib>Yuan, Long ; Lin, Zhoumeng ; Dutch, Rachel S. ; Richards, Emily D. ; Clapham, Maaike O. ; Burmas, Nathaniel ; Wetzlich, Scott E. ; Tell, Lisa A.</creatorcontrib><description>Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) commonly prescribed in an extralabel manner for treating chickens in urbanized settings. The objectives of this study were to determine meloxicam depletion profiles in eggs and ovarian follicles and to estimate associated withdrawal intervals (WDI) in laying hens following a single intravenous or repeated oral administration. The observed peak concentration of meloxicam in ovarian follicles were consistently higher than in egg yolk and egg white samples. Terminal half-lives were 31-h, 113-h and 12-h in ovarian follicles, egg yolk and egg white samples, respectively, for repeated oral administrations at 1 mg/kg for 20 doses at 12-h intervals. The terminal half-life following a single intravenous administration at 1 mg/kg was 50-h for ovarian follicles. Meloxicam WDI estimations using ovarian follicle and egg yolk concentration data following 20 doses at 12-h intervals were 36 and 12 days, respectively. Meloxicam WDI estimation using egg yolk concentration data following 8 doses at 24-h intervals was 12 days. These results improve our understanding on the residue depletion of meloxicam from chickens’ reproductive tracts and egg products and provide WDIs to help ensure food safety for humans consuming eggs from treated laying hens. •Meloxicam residue depletion kinetics in eggs and follicles of chickens was studied.•Maximum concentration in ovarian follicles was higher than in egg yolk and white.•Withdrawal interval (WDI) was 12 days in egg yolk after repeated oral exposures.•WDI was 36 days based on follicle data after repeated oral administrations.•The results help derive extralabel WDI to provide safe egg products.</description><identifier>ISSN: 0273-2300</identifier><identifier>EISSN: 1096-0295</identifier><identifier>DOI: 10.1016/j.yrtph.2022.105170</identifier><identifier>PMID: 35460801</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>Drug residue ; Egg withdrawal time ; Meloxicam ; Pharmacokinetics ; Tissue residue depletion</subject><ispartof>Regulatory toxicology and pharmacology, 2022-07, Vol.132, p.105170-105170, Article 105170</ispartof><rights>2022 The Authors</rights><rights>Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c334t-d07fa81c0b4561d5e72252559a1118f12035b3d8baebae6512870f902deb50383</citedby><cites>FETCH-LOGICAL-c334t-d07fa81c0b4561d5e72252559a1118f12035b3d8baebae6512870f902deb50383</cites><orcidid>0000-0003-1823-7420 ; 0000-0002-8731-8366</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35460801$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yuan, Long</creatorcontrib><creatorcontrib>Lin, Zhoumeng</creatorcontrib><creatorcontrib>Dutch, Rachel S.</creatorcontrib><creatorcontrib>Richards, Emily D.</creatorcontrib><creatorcontrib>Clapham, Maaike O.</creatorcontrib><creatorcontrib>Burmas, Nathaniel</creatorcontrib><creatorcontrib>Wetzlich, Scott E.</creatorcontrib><creatorcontrib>Tell, Lisa A.</creatorcontrib><title>Residue depletion profiles and withdrawal interval estimations of meloxicam in eggs and ovarian follicles following intravenous (Meloxicam solution for injection) and oral (Meloxidyl®) administration in domestic chickens (Gallus domesticus)</title><title>Regulatory toxicology and pharmacology</title><addtitle>Regul Toxicol Pharmacol</addtitle><description>Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) commonly prescribed in an extralabel manner for treating chickens in urbanized settings. The objectives of this study were to determine meloxicam depletion profiles in eggs and ovarian follicles and to estimate associated withdrawal intervals (WDI) in laying hens following a single intravenous or repeated oral administration. The observed peak concentration of meloxicam in ovarian follicles were consistently higher than in egg yolk and egg white samples. Terminal half-lives were 31-h, 113-h and 12-h in ovarian follicles, egg yolk and egg white samples, respectively, for repeated oral administrations at 1 mg/kg for 20 doses at 12-h intervals. The terminal half-life following a single intravenous administration at 1 mg/kg was 50-h for ovarian follicles. Meloxicam WDI estimations using ovarian follicle and egg yolk concentration data following 20 doses at 12-h intervals were 36 and 12 days, respectively. Meloxicam WDI estimation using egg yolk concentration data following 8 doses at 24-h intervals was 12 days. These results improve our understanding on the residue depletion of meloxicam from chickens’ reproductive tracts and egg products and provide WDIs to help ensure food safety for humans consuming eggs from treated laying hens. •Meloxicam residue depletion kinetics in eggs and follicles of chickens was studied.•Maximum concentration in ovarian follicles was higher than in egg yolk and white.•Withdrawal interval (WDI) was 12 days in egg yolk after repeated oral exposures.•WDI was 36 days based on follicle data after repeated oral administrations.•The results help derive extralabel WDI to provide safe egg products.</description><subject>Drug residue</subject><subject>Egg withdrawal time</subject><subject>Meloxicam</subject><subject>Pharmacokinetics</subject><subject>Tissue residue depletion</subject><issn>0273-2300</issn><issn>1096-0295</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9UU2O0zAUjhCIKQMnQEJedhYpz06cnwULNBpmkAYhIVhbjv3SujhxsZOWXopDcCNuME7TmSWSJdvP38_z-5LkLYUVBVq8366OfthtVgwYixVOS3iWLCjURQqs5s-TBbAyS1kGcJG8CmELAKyqypfJRcbzAiqgi-TfNwxGj0g07iwOxvVk511rLAYie00OZthoLw_SEtMP6PfxgGEwnZywgbiWdGjdb6NkFxEE1-uZ6PbSG9mT1llr1CQ3ndzB9OtJycs99m4MZPnliR6cHU8dtM5HzBbVdLua5Xw0PmP10f79E8u6M70JUepEiubadVNviqiNUT8xtre8ldZGl8eXMVy9Tl600gZ8c94vkx-fbr5f36X3X28_X3-8T1WW5UOqoWxlRRU0OS-o5lgyxhnntaSUVi1lkPEm01UjMa6CU1aV0NbANDYcsiq7TJazbpznrzG6i84EhdbKHuPHBSt4zsq6zCdoNkOVdyF4bMXOxwn7o6AgpqzFVpyyFlPWYs46st6dDcamQ_3EeQw3Aj7MAIzf3Bv0IiiDvUJtfJyt0M781-ABSbHDiw</recordid><startdate>202207</startdate><enddate>202207</enddate><creator>Yuan, Long</creator><creator>Lin, Zhoumeng</creator><creator>Dutch, Rachel S.</creator><creator>Richards, Emily D.</creator><creator>Clapham, Maaike O.</creator><creator>Burmas, Nathaniel</creator><creator>Wetzlich, Scott E.</creator><creator>Tell, Lisa A.</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1823-7420</orcidid><orcidid>https://orcid.org/0000-0002-8731-8366</orcidid></search><sort><creationdate>202207</creationdate><title>Residue depletion profiles and withdrawal interval estimations of meloxicam in eggs and ovarian follicles following intravenous (Meloxicam solution for injection) and oral (Meloxidyl®) administration in domestic chickens (Gallus domesticus)</title><author>Yuan, Long ; Lin, Zhoumeng ; Dutch, Rachel S. ; Richards, Emily D. ; Clapham, Maaike O. ; Burmas, Nathaniel ; Wetzlich, Scott E. ; Tell, Lisa A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c334t-d07fa81c0b4561d5e72252559a1118f12035b3d8baebae6512870f902deb50383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Drug residue</topic><topic>Egg withdrawal time</topic><topic>Meloxicam</topic><topic>Pharmacokinetics</topic><topic>Tissue residue depletion</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yuan, Long</creatorcontrib><creatorcontrib>Lin, Zhoumeng</creatorcontrib><creatorcontrib>Dutch, Rachel S.</creatorcontrib><creatorcontrib>Richards, Emily D.</creatorcontrib><creatorcontrib>Clapham, Maaike O.</creatorcontrib><creatorcontrib>Burmas, Nathaniel</creatorcontrib><creatorcontrib>Wetzlich, Scott E.</creatorcontrib><creatorcontrib>Tell, Lisa A.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Regulatory toxicology and pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yuan, Long</au><au>Lin, Zhoumeng</au><au>Dutch, Rachel S.</au><au>Richards, Emily D.</au><au>Clapham, Maaike O.</au><au>Burmas, Nathaniel</au><au>Wetzlich, Scott E.</au><au>Tell, Lisa A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Residue depletion profiles and withdrawal interval estimations of meloxicam in eggs and ovarian follicles following intravenous (Meloxicam solution for injection) and oral (Meloxidyl®) administration in domestic chickens (Gallus domesticus)</atitle><jtitle>Regulatory toxicology and pharmacology</jtitle><addtitle>Regul Toxicol Pharmacol</addtitle><date>2022-07</date><risdate>2022</risdate><volume>132</volume><spage>105170</spage><epage>105170</epage><pages>105170-105170</pages><artnum>105170</artnum><issn>0273-2300</issn><eissn>1096-0295</eissn><abstract>Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) commonly prescribed in an extralabel manner for treating chickens in urbanized settings. The objectives of this study were to determine meloxicam depletion profiles in eggs and ovarian follicles and to estimate associated withdrawal intervals (WDI) in laying hens following a single intravenous or repeated oral administration. The observed peak concentration of meloxicam in ovarian follicles were consistently higher than in egg yolk and egg white samples. Terminal half-lives were 31-h, 113-h and 12-h in ovarian follicles, egg yolk and egg white samples, respectively, for repeated oral administrations at 1 mg/kg for 20 doses at 12-h intervals. The terminal half-life following a single intravenous administration at 1 mg/kg was 50-h for ovarian follicles. Meloxicam WDI estimations using ovarian follicle and egg yolk concentration data following 20 doses at 12-h intervals were 36 and 12 days, respectively. Meloxicam WDI estimation using egg yolk concentration data following 8 doses at 24-h intervals was 12 days. These results improve our understanding on the residue depletion of meloxicam from chickens’ reproductive tracts and egg products and provide WDIs to help ensure food safety for humans consuming eggs from treated laying hens. •Meloxicam residue depletion kinetics in eggs and follicles of chickens was studied.•Maximum concentration in ovarian follicles was higher than in egg yolk and white.•Withdrawal interval (WDI) was 12 days in egg yolk after repeated oral exposures.•WDI was 36 days based on follicle data after repeated oral administrations.•The results help derive extralabel WDI to provide safe egg products.</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>35460801</pmid><doi>10.1016/j.yrtph.2022.105170</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-1823-7420</orcidid><orcidid>https://orcid.org/0000-0002-8731-8366</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0273-2300
ispartof Regulatory toxicology and pharmacology, 2022-07, Vol.132, p.105170-105170, Article 105170
issn 0273-2300
1096-0295
language eng
recordid cdi_proquest_miscellaneous_2654279748
source ScienceDirect Freedom Collection
subjects Drug residue
Egg withdrawal time
Meloxicam
Pharmacokinetics
Tissue residue depletion
title Residue depletion profiles and withdrawal interval estimations of meloxicam in eggs and ovarian follicles following intravenous (Meloxicam solution for injection) and oral (Meloxidyl®) administration in domestic chickens (Gallus domesticus)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T19%3A16%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Residue%20depletion%20profiles%20and%20withdrawal%20interval%20estimations%20of%20meloxicam%20in%20eggs%20and%20ovarian%20follicles%20following%20intravenous%20(Meloxicam%20solution%20for%20injection)%20and%20oral%20(Meloxidyl%C2%AE)%20administration%20in%20domestic%20chickens%20(Gallus%20domesticus)&rft.jtitle=Regulatory%20toxicology%20and%20pharmacology&rft.au=Yuan,%20Long&rft.date=2022-07&rft.volume=132&rft.spage=105170&rft.epage=105170&rft.pages=105170-105170&rft.artnum=105170&rft.issn=0273-2300&rft.eissn=1096-0295&rft_id=info:doi/10.1016/j.yrtph.2022.105170&rft_dat=%3Cproquest_cross%3E2654279748%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c334t-d07fa81c0b4561d5e72252559a1118f12035b3d8baebae6512870f902deb50383%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2654279748&rft_id=info:pmid/35460801&rfr_iscdi=true